Intermediate-term outcome of 500 consecutive rapid-deployment surgical aortic valve procedures†.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
01 Mar 2019
Historique:
received: 16 04 2018
revised: 27 06 2018
accepted: 08 07 2018
pubmed: 24 8 2018
medline: 2 10 2020
entrez: 24 8 2018
Statut: ppublish

Résumé

The Edwards INTUITY Valve System is a balloon-expandable bioprosthesis, inspired from the Edwards Magna valve and transcatheter technology, with a subvalvular stent frame to enable rapid deployment. We report a single-centre experience of aortic valve replacement with this novel bioprosthesis. Five hundred consecutive patients, of whom 45.6% were female with a mean age of 73.5 [standard deviation (SD) 7.9 years], with severe aortic stenosis who received a rapid deployment aortic valve between May 2010 and July 2017 were included in a prospective and ongoing database. The median follow-up time was 12 months, and the total accumulated follow-up time was 818 patient years. Preoperative characteristics, operative parameters, survival, valve-related adverse events and valve haemodynamics were assessed. Thirty-day mortality was 0.8% (4/500), and overall survival at 1, 3 and 5 years was 94%, 89% and 81%, respectively. A minimally invasive surgical approach was chosen in 236 patients (47%), of which 122 (24%) were operated on through an anterior right thoracotomy. Cross-clamp and cardiopulmonary bypass times for isolated aortic valve replacement were 53 (SD 17) and 89 (SD 29) min for full sternotomy as well as 75 (SD 23) and 110 (SD 31) min for minimally invasive surgery approaches (P < 0.001). Mean gradients at discharge, 1, 3 and 5 years were 13 (SD 5), 11 (SD 4), 12 (SD 5) and 11 (SD 3) mmHg, respectively. New pacemaker implantation was necessary in 8.6% of patients. A single case (0.2%) of structural degeneration was registered after 6 years. Valve explantation for non-structural dysfunction or endocarditis occurred in 9 patients (1.8%). This rapid deployment aortic valve has shown excellent results concerning haemodynamic performance, durability and safety. Implantation requires specific training, and the rate of pacemaker implantation remains a matter of concern. This novel valve also facilitates minimally invasive approaches and may be beneficial in complex combined procedures.

Identifiants

pubmed: 30137264
pii: 5076726
doi: 10.1093/ejcts/ezy273
pmc: PMC6381385
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

527-533

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.

Références

Ann Thorac Surg. 2016 Feb;101(2):789-800
pubmed: 27175453
Eur J Cardiothorac Surg. 2017 Aug 1;52(2):281-287
pubmed: 28453629
JACC Cardiovasc Interv. 2017 Feb 13;10(3):268-275
pubmed: 28183466
J Thorac Cardiovasc Surg. 2017 Jul;154(1):32-43.e1
pubmed: 28433356
Ann Thorac Surg. 2017 Oct;104(4):1259-1264
pubmed: 28433222
J Am Heart Assoc. 2018 Feb 16;7(4):
pubmed: 29453309
Ann Thorac Surg. 2014 Oct;98(4):1294-300
pubmed: 25106682
Eur J Cardiothorac Surg. 2018 Oct 1;54(4):768-773
pubmed: 29617925
N Engl J Med. 2017 Apr 6;376(14):1321-1331
pubmed: 28304219
J Thorac Cardiovasc Surg. 2014 Dec;148(6):2854-60
pubmed: 25218544
N Engl J Med. 2016 Apr 28;374(17):1609-20
pubmed: 27040324
Lancet. 2016 May 28;387(10034):2218-25
pubmed: 27053442
J Thorac Cardiovasc Surg. 2013 Jan;145(1):110-5; discussion 115-6
pubmed: 23058665
EuroIntervention. 2018 Mar 20;13(16):1902-1903
pubmed: 29175769
Eur J Cardiothorac Surg. 2015 Oct;48(4):557-61
pubmed: 25527170
Interact Cardiovasc Thorac Surg. 2016 Jun;22(6):799-805
pubmed: 26976130
Lancet. 2015 Jun 20;385(9986):2477-84
pubmed: 25788234
JAMA Cardiol. 2016 Nov 1;1(8):945-949
pubmed: 27541162
Innovations (Phila). 2018 May/Jun;13(3):177-183
pubmed: 29912142
Eur J Cardiothorac Surg. 2008 Apr;33(4):523-8
pubmed: 18313319
Ann Thorac Surg. 1996 Aug;62(2):596-7
pubmed: 8694642
Ann Thorac Surg. 2015 Jan;99(1):17-25
pubmed: 25441065
Ann Thorac Surg. 2018 Jul;106(1):14-22
pubmed: 29630873
J Thorac Cardiovasc Surg. 2009 Mar;137(3):670-679.e5
pubmed: 19258087
J Am Soc Echocardiogr. 2009 Sep;22(9):975-1014; quiz 1082-4
pubmed: 19733789
Cardiovasc Eng Technol. 2017 Mar;8(1):17-29
pubmed: 27873180

Auteurs

Martin Andreas (M)

Department of Surgery, Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Iuliana Coti (I)

Department of Surgery, Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Raphael Rosenhek (R)

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Shiva Shabanian (S)

Department of Surgery, Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Stephane Mahr (S)

Department of Surgery, Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Keziban Uyanik-Uenal (K)

Department of Surgery, Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Dominik Wiedemann (D)

Department of Surgery, Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Thomas Binder (T)

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Alfred Kocher (A)

Department of Surgery, Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Guenther Laufer (G)

Department of Surgery, Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH